1 |
Dickson, D.W., Lee, S.C, Mattiace, L.A., Yen, S.H., and Brosnan, C., Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 7,75-83, 1993.
|
2 |
Banati, R.B., Gehrmann, J., Schubert, P., Kreutzberg, G.W., Cytotoxicity of microglia. Glia, 7, 111-118, 1996.
|
3 |
Giulian, D., Ameboid microglia as effectors of inflammation in the central nervous system. J. Neuroscience. Res., 18, 155-171, 1987.
|
4 |
Kim, W.G., Mohney, R.P., Wilson, B., Heohn, G.H., Liu, B., and Hong, J.S., Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J. Neurosci., 20, 6309-6316, 2000.
|
5 |
Yanker, B.A., Duffy, L.K., and Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid protein: Reversal by tachykinin neuropeptide. Science, 250, 279-282, 1990.
|
6 |
Calmus, Y.P., Podevin, P., Poupun, R., Dirrefntial effects of chenodeoxycholic and ursodeoxycholic acid on interleukin-1, interleukin-6, and tumor necrosis factor- production by monocytes. Hepatology, 16,719-723, 1992.
|
7 |
Lin, T.J., Hirji, N., Stenton, G.R., Gilchrist, M., Grill, B.J., Schreiber, A.D., and Befus, A.D., Activation of Macropharge CD8: Pharmacological Studies of TNF and IL-I Production. J. Immunol., 164, 1783-1792, 2000.
|
8 |
Benveniste, E.N., Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol, 263, C1-16, 1992.
|
9 |
Mrak, R.E., Sheng, J.G., Griffin, W.S.T., Glial cytokines in Alzheimer's disease: reveiwand pathogenic implication. Hum. Pathol., 26, 816-823, 1995.
|
10 |
Sheng, J.G., Ito, K., Skinner, R.D., Mrak, C.R., Van Eldik, L.J., Griffin, W.S.T., In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging.,17, 761-766, 1996.
|
11 |
Bowie, A., and O'Neill, L.A.J., Oxidative stress and nuclear Pactor- B activation; a reassessment of the evidence in the light of recent discoveries. Biochemical Pharmacology, 59, 13-23, 2000.
DOI
ScienceOn
|
12 |
Rodrigues, C.M.P., Ma, X., Kren, B.T., and Streer, C.J., A novel role for ursodeoxycholic acid in inhibiting apotosis by modulating mitochondrial membrane perturbation. J. clin. Invest., 101(12), 2790-2799, 1998.
|
13 |
Bayer, T.A., Wirths, O., Majtenyl, K., Hartmann, T., Multhaup, G., Beyreuther, K., and Czech, C., Key factors in Alzheimer's disease: -amyloid precursor protein processing, metabolism, and intraneuronal transport. Brain Pathology, 11, 1-11, 2001.
|
14 |
Ljubuncic, P., Fuhrman, B., Oiknine, J., Aviram, M., and Bomzon, A., Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut., 39(3), 475-478, 1996.
|
15 |
Mrak, R.E., Sheng, J.G., Griffin, W.S.T., Glial cytokines in Alzheimer's disease: reveiwand pathogenic implication. Hum. Pathol., 26, 816-823, 1995.
DOI
ScienceOn
|
16 |
Forloni, G., Demichelli, F., Giorgi, S., Bendotti, C., and Angeretti, N., Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cell: modulation by interleukin-1, Brain. Res., 16, 128-134, 1992.
|
17 |
Jaffrey, S.R., and Snyder, S.H., Nitric oxide: a nral messenger. Annu. Rev. Cell. Dev., 11, 417-440, 1995.
|
18 |
Lue, L.F., and Walker, D.G., Modeling Alzheimer's disease immune therapy mechanisms; interaction of human postmortem microglia with antibody-opsonized amyloid beta peptide. J Neurosci Res., 70, 599-610, 2002.
|
19 |
Tanaka, H., Makino, Y., Miura, T., Hirano, F., Okamoto, K., Komura, K., Sato, Y., Makino, I., Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of the IFN- gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J. Immunology, 156,1601-1608, 1996.
|
20 |
Giulian, D., Baker, T.J., Shih, L., and Lachman, L.B., Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med, 164, 594, 1986.
|
21 |
Chao, C.C.. Hu, S., Molitor, T.W., Shaskan, E.C., and Peterson, P.K., Activated microglia mediated neuronal cell injury via a nitric oxide mechanism. J. Immunol, 149, 2736-2741, 1992.
|
22 |
Possel, H., Noack, H., Putzke, J., Wolf, G., and Sies, H., Selective upregulation of inducible Nitric Oxide Synthase (iNOS) by lipopolysaccharide(LPS) and cytokines in microglia. Glia, 32, 51-59, 2000.
|
23 |
Meda, L., Cassatella, M.A., Szendrei, G.I., Baron, P., Villalba, M., Ferrari, D., and Rossi, F., Activation of microglia cell by -amyloid protein and interferon- . Nature, 374, 647-650, 1995.
|
24 |
Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D.A., Review: Alzheimer's amyloid beta-peptide associated free radical oxidative stress and neurotoxicity. J. Structural Biol., 130, 184-208, 2000.
|
25 |
Gouras, G.K., Current theories for the molecular and cellular pathogenesis of Alzheimer's disease. Expert review in molecular medicine. Cambridge University Press, 2001.
|
26 |
Lacaille, F., K Paradis, K., The immunosuppressive effect of ursodexycholic, a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology, 18, 165-172, 1993.
|
27 |
Selkoe, D.J., The molecular pathology of Alzheimer's disease. Neuron, 6, 487-498, 1991.
|
28 |
Lue, L., Rydel, R., Brigham, E.F., Yang, L., Hampek, H., Murphy, G.M., Brachova, L., Yan, S., Walker, D.G., Shen, Y., and Rogers, J., Imflammatory receptories of Alzheimer's disease and non demented elderly microglia in vitro. Glia., 35, 72-79, 2001.
|
29 |
Paresce, D.M., H, Chung, and Maxfield., Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272, 29390-29397, 1997.
|
30 |
Strijbos, P.J., and Rothwell, N.J., Interleukin-1beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci., 153, 3468-3474, 1995.
|